DIABETES MELLITUS-INDUCED HYPERSENSITIVITY OF MOUSE SKELETAL-MUSCLES TO ACETYLCHOLINE AND SUCCINYLCHOLINE

被引:19
作者
KIMURA, M [1 ]
KIMURA, I [1 ]
NOJIMA, H [1 ]
MUROI, M [1 ]
机构
[1] TOYAMA MED & PHARMACEUT UNIV, FAC PHARMACEUT SCI, DEPT CHEM PHARMACOL, SUGITANI, TOYAMA 93001, JAPAN
关键词
D O I
10.1254/jjp.40.251
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The myopathy in skeletal muscles of genetically diabetic male KK-CAy mice or alloxan-induced diabetic mice was investigated. In these diabetic mice, nerve-stimulated twitch tensions of in situ sciatic nerve-gastrocnemius muscle preparations were inhibited by intraarterially administered succinylcholine (SuCh) to a greater extent than in normal (non-diabetic) ones. Despite the high blood glucose level, at one week after alloxan administration, no hypersensitivity to SuCh was induced in mice, but mice at 2 weeks and 4 weeks after alloxan showed greater sensitivities. In isolated diaphragm muscles of diabetic KK-Cay mice, the acetylcholine (ACh, iontophoretically applied) potential amplitude was greater than in KK-CAy prediabetic muscles. SuCh in diabetic KK-CAy muscles inhibited ACh potentials to a greater extent than in normal ddY muscles. Hill coefficients obtained from the inhibition curve by SuCh of the nerve-stimulation response were decreased by the diabetic state. The sensitivities to d-tubocurarine and .alpha.-bungarotoxin were the same in both kinds of muscles. Both extrajunctional ACh receptors in denervated muscles of normal ddY and diabetic KK-CA7 mice revealed the lower sensitivity to SuCh than junctional receptors in non-denervated normal muscles. In conclusion, diabetic muscles showed the hypersensitivity restricted to SuCh. These phenomena are neither due to glycosylation nor to denervation supersensitivity.
引用
收藏
页码:251 / 256
页数:6
相关论文
共 10 条
[1]   DIABETIC NEUROPATHY - NEW CONCEPTS OF ITS ETIOLOGY [J].
CLEMENTS, RS .
DIABETES, 1979, 28 (06) :604-611
[2]  
ELMQVIST D, 1960, ACTA PHARMACOL TOX, V17, P84
[4]  
Hill AV, 1909, J PHYSIOL-LONDON, V39, P361
[5]  
KIMURA M, 1979, ENDOCRINOL JAPON, V26, P185
[6]  
KIMURA M, 1985, FOLIA PHARMACOL JPN, V85, pP97
[7]  
Kondo K., 1957, B EXPT ANIMALS, V6, P107, DOI [DOI 10.11501/1756299, 10.11501/1756299]
[8]  
MINKER E, 1966, ACTA PHYSIOL HUNG, V29, P410
[9]  
Nishimura, 1969, Exp. Anim, V18, P147, DOI DOI 10.1538/EXPANIM1957.18.4_147
[10]  
SCHOFIELD GG, 1978, ACTA DIABETOL LAT, V15, P287, DOI 10.1007/BF02590752